Treating Ebola And Beyond: Spotlight On Novel Hemopurifier
Executive Summary
Aethlon Medical’s Hemopurifier device was successfully used in Germany to treat a Ugandan physician with Ebola, and now the company is preparing to launch its first human clinical studies in the US. Aethlon hopes this novel device will provide a first-in-class broad-spectrum treatment countermeasure against pandemic threats such as Ebola and chronic viral pathogens.
You may also be interested in...
WHO Launches Initiatives For Ebola POC Tests
The World Health Organization has initiated a rapid review process and is providing early test validation materials to encourage more manufacturers to quickly develop rapid, point-of-care Ebola tests. Meanwhile, Aethlon Medical is providing its bio-filtration device to treat blood of Ebola patients.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.